Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehiro Katayama

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Journal of Clinical Medicine Research|March 18, 2015
The efficacy of vildagliptin concomitant with insulin therapy in type 2 diabetic subjectsDaisuke Ito, Kazuyuki Inoue, Kimie Kaneko, et al.
Brain Research|September 18, 2012
Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes ratsRie Suge, Tomokazu Shimazu, Hajime Hasegawa, et al.
Journal of Atherosclerosis and Thrombosis|January 23, 2010
A promoter in the novel exon of hPPARgamma directs the circadian expression of PPARgammaSeiichiro Takahashi, Ikuo Inoue, Yoshihiro Nakajima, et al.
Biochemical and Biophysical Research Communications|July 31, 2007
Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathyHiroyuki Iizuka, Takuya Awata, Masataka Osaki, et al.
Journal of the American Society of Nephrology : JASN|July 16, 2011
Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imagingTsutomu Inoue, Eito Kozawa, Hirokazu Okada, et al.
Journal of Atherosclerosis and Thrombosis|May 13, 2003
Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor gamma 1 (PPARgamma 1) and PPARalpha genesIkuo Inoue, Kenji Hayashi, Fumiharu Yagasaki, et al.
Journal of Atherosclerosis and Thrombosis|October 18, 2003
A patient with severe hypertriglyceridemia associated with anemia and hypoalbuminemiaIkuo Inoue, Hea Saeng Koh, Kasumi Mizotani, et al.
Diabetes Care|February 17, 2012
Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications StudyHirohito Sone, Sachiko Tanaka, Shiro Tanaka, et al.
Diabetes Care|February 14, 2013
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engineShiro Tanaka, Sachiko Tanaka, Satoshi Iimuro, et al.
Clinical and Experimental Nephrology|December 25, 2017
The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trialKoichi Kanozawa, Yuichi Noguchi, Souichi Sugahara, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Journal of Clinical Medicine Research|March 18, 2015
The efficacy of vildagliptin concomitant with insulin therapy in type 2 diabetic subjectsDaisuke Ito, Kazuyuki Inoue, Kimie Kaneko, et al.
Brain Research|September 18, 2012
Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes ratsRie Suge, Tomokazu Shimazu, Hajime Hasegawa, et al.
Journal of Atherosclerosis and Thrombosis|January 23, 2010
A promoter in the novel exon of hPPARgamma directs the circadian expression of PPARgammaSeiichiro Takahashi, Ikuo Inoue, Yoshihiro Nakajima, et al.
Biochemical and Biophysical Research Communications|July 31, 2007
Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathyHiroyuki Iizuka, Takuya Awata, Masataka Osaki, et al.
Journal of the American Society of Nephrology : JASN|July 16, 2011
Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imagingTsutomu Inoue, Eito Kozawa, Hirokazu Okada, et al.
Journal of Atherosclerosis and Thrombosis|May 13, 2003
Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor gamma 1 (PPARgamma 1) and PPARalpha genesIkuo Inoue, Kenji Hayashi, Fumiharu Yagasaki, et al.
Journal of Atherosclerosis and Thrombosis|October 18, 2003
A patient with severe hypertriglyceridemia associated with anemia and hypoalbuminemiaIkuo Inoue, Hea Saeng Koh, Kasumi Mizotani, et al.
Diabetes Care|February 17, 2012
Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications StudyHirohito Sone, Sachiko Tanaka, Shiro Tanaka, et al.
Diabetes Care|February 14, 2013
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engineShiro Tanaka, Sachiko Tanaka, Satoshi Iimuro, et al.
Clinical and Experimental Nephrology|December 25, 2017
The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trialKoichi Kanozawa, Yuichi Noguchi, Souichi Sugahara, et al.
Pageof 13